|
2022
|
Invention
|
Tunable transposon systems.
This invention provides methods and systems for enhancement of prote... |
|
2021
|
Invention
|
Tunable transposon systems. This invention provides methods and systems for enhancement of protei... |
|
2020
|
Invention
|
Methods of enhancing and expediting expression of antibodies.
This application describes cells, ... |
|
|
Invention
|
Methods of enhancing and expediting expression of antibodies. This application describes cells, s... |
|
|
Invention
|
Thermostable quick-disolving thin film.
The present invention relates to thermostable quick-diss... |
|
|
Invention
|
Thermostable quick-disolving thin film. The present invention relates to thermostable quick-disso... |
|
2019
|
Invention
|
Acinetobacter baumannii . Acinetobacter and compositions comprising these polypeptides. The inven... |
|
2018
|
Invention
|
Compositions and methods against p. aeruginosa infections.
A combination of an antibody and othe... |
|
|
Invention
|
Compositions and methods against p. aeruginosa infections. A combination of an antibody and other... |
|
|
Invention
|
Targets of acinetobacter baumannii. Acinetobacter and compositions comprising these polypeptides.... |
|
|
Invention
|
Acinetobacter baumannii. Acinetobacter and compositions comprising these polypeptides. The invent... |
|
2017
|
Invention
|
Method for preparation of quick dissolving thin films containing bioactive material with enhanced... |
|
2015
|
Invention
|
Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv). −9M. P... |
|
|
Invention
|
Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv). This i... |
|
|
G/S
|
Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmace... |
|
2014
|
Invention
|
Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv). −9 M. ... |
|
2012
|
Invention
|
Novel targets of acinetobacter baumannii. The present invention provides antigenic polypeptides e... |
|
2010
|
Invention
|
S. aureus derived alpha-toxin and its use in treating or preventing abscess formation. S. aureus,... |
|
|
Invention
|
Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preven... |
|
|
Invention
|
Gallium formulation for the treatment and prevention of infectious diseases. Pseudomonas aerugino... |
